Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-16 · accession 0001104659-21-151321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-17 | 2021-12-16 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $14.40 | +1,744 | 107.8K | +2% | +$25.1K |
| D | 2021-12-17 | 2021-12-16 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $22.40 | -1,744 | 106.0K | -2% | -$39.1K |
| D | 2021-12-17 | 2021-12-16 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -1,744 | 116.8K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | M | A | 1,744 | $14.40 | 107,786 | D | — | — | (F2) Includes 353 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2021. |
| 2 | Common | Common Stock | 2021-12-16 | S | D | 1,744 | $22.40 | 106,042 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-12-16 | M | D | 1,744 | $0.00 | 116,809 | D | $14.40 · — to 2024-04-21 | 1,744 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |